| Drug Name: | Copper (7440-50-8) |
|---|---|
| PubChem ID: | 23978 |
| SMILES: | [Cu] |
| InchiKey: | RYGMFSIKBFXOCR-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 63.546 |
| LogP | : | -0.0025 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 0 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 0 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Abnormal Metallothionein Gene Regulation | Metallothionein (P04731) | Abnormal metallothionein gene regulation in response to copper [ ADR Type 2 ] | Menkes' disease: abnormal metallothionein gene regulation in response to copper |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category